Welcome to our dedicated page for HERBALIFE LTD. SEC filings (Ticker: HLF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Herbalife Ltd. filings document the regulatory record of a Cayman Islands health and wellness company with common shares listed on the New York Stock Exchange under HLF. Form 8-K reports cover quarterly and annual financial results, Regulation FD materials, material definitive agreements, senior secured notes due 2033, and amendments to secured credit facilities involving company subsidiaries.
Proxy materials cover annual general meeting procedures, shareholder voting matters, and governance. The filings also describe capital-structure subjects, security registration details, and formal disclosures related to the company’s products, network marketing program, and legal or regulatory risk areas.
Herbalife Ltd. reports Schedule 13G/A ownership disclosure. As of March 31, 2026, Nantahala Capital Management, LLC and its managers beneficially own 6,953,653 common shares, representing 6.72% of the outstanding Common Shares. The filing states shared voting and dispositive power over these shares.
HERBALIFE LTD. Chief Commercial Officer Frank Lamberti reported selling a total of 142,919 shares of common stock in open-market transactions. On May 12, 2026, he sold 134,982 shares at $13.50 per share, and on May 11, 2026, he sold 7,937 shares at a weighted average price of $13.8594 per share.
The filing notes that the 7,937-share sale occurred in multiple trades at prices ranging from $13.85 to $13.8601 per share. Following these sales, Lamberti directly holds 36,624 shares of Herbalife common stock.
Cloud Lynda reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. director Lynda Cloud received an equity award of 11,879 shares of Common Stock in the form of restricted stock units. The grant carried a price of $0.00 per share as it is compensation, not an open-market purchase. These RSUs will vest 100% on April 15, 2027, if she continues serving on the Board through that date, and her direct holdings after the award total 50,736 shares.
Otero Maria reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. director Maria Otero received a grant of 11,879 restricted stock units (RSUs) of common stock as compensation, at no cash purchase price. These RSUs were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan.
The RSUs will vest 100% on April 15, 2027, if she continues to serve on the Board through that date. Following this grant and the inclusion of 3,200 shares previously omitted from earlier reports, Otero now holds 95,129 shares of Herbalife common stock directly.
Carmona Richard H reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. director Richard H. Carmona received a grant of 11,879 shares of Common Stock in the form of restricted stock units. These RSUs were granted at no cash cost and increase his direct holdings to 83,645 shares after the transaction.
The RSUs were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. They will vest 100% on April 15, 2027, provided Carmona continues to serve on the company’s Board of Directors through that date.
LEVITT MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. director Michael J. Levitt received an equity grant in the form of 11,879 restricted stock units (RSUs) on May 8, 2026. The award was granted at no cash cost per unit and was made under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan.
The RSUs will vest 100% on April 15, 2027, as long as Levitt continues to serve on the Board of Directors through that date. After this grant, his directly held equity position reported in this filing totals 49,393 shares or units of common stock-based holdings.
Mendoza Juan Miguel reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. director Juan Miguel Mendoza received a grant of 11,879 shares of common stock in the form of restricted stock units (RSUs). The award was granted at no cash cost per share and is part of his equity compensation.
The RSUs were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan and will vest 100% on April 15, 2027, as long as he continues serving on the company’s Board of Directors through that date. After this grant, Mendoza holds a total of 181,879 shares of common stock directly.
Walsh Des reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. director Des Walsh received an equity grant of 11,879 shares of Common Stock in the form of restricted stock units under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These RSUs carry no cash purchase price.
The RSUs will vest 100% on April 15, 2027, as long as Walsh continues to serve on the company’s Board of Directors through that date. After this award, he holds 61,879 shares directly and 200,000 shares indirectly through a trust.
HERBALIFE LTD. director Rodica Macadrai received a grant of 11,879 shares of Common Stock in the form of restricted stock units as compensation. The award carries no cash exercise price. After this grant, she directly holds 67,441 shares in total.
The restricted stock units were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan and will vest 100% on April 15, 2027, provided she continues to serve on the Board of Directors through that date.